<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="http://dx.doi.org/10.17917/0DFX-GC30" scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
            table { border: 1px solid #dddddd; text-align: left; padding: 8px }
            td, th { border: 1px solid #dddddd; text-align: left; padding: 8px }
            tr:nth-child(even) { background-color: #dddddd }
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><p><b>Protocol Type:</b> Endotoxin</p><p><b>Protocol Name:</b> NCL Method STE-1.1: Detection and Quantification of Gram-Negative Bacterial Endotoxin Contamination in Nanoparticle Formulations Using the End Point Chromogenic LAL Assay</p><p><b>Protocol Abbreviation:</b> STE-1.1</p><p><b>Protocol Version:</b> 3.1<hr><p><b>DOI:</b> <a href = http://dx.doi.org/10.17917/0DFX-GC30>http://dx.doi.org/10.17917/0DFX-GC30</a></p><p><b>Protocol File:</b> NCL_Method_STE-1.1.pdf<p><b>File Title:</b> STE-1.1</p><p><b>Description:</b></b> This document describes a protocol for a quantitative detection of Gram negative bacterial endotoxin in nanoparticle preparations using an end-point Limulus Amebocyte Lysate (LAL) assay. The protocol is based on the QCL-1000 kit manufactured by Lonza Corporation and the USP standard 85 ‚ÄúBacterial endotoxin test."<hr><p><b>Resource Type:</b>  Protocol</p><p><b>Data Access:</b> <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a><p></body></html>